array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "ROCHE DIAGNOSTICS LIMITED"
["slug"]=>
string(34) "ef866-gb-roche-diagnostics-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c"
["description"]=>
string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation"
["address_street"]=>
string(14) "Charles Avenue"
["address_place"]=>
string(12) "BURGESS HILL"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1956-09-14"
["website_domain"]=>
string(9) "roche.com"
["website_url"]=>
string(29) "https://diagnostics.roche.com"
["industry_codes"]=>
array(1) {
[0]=>
string(43) "Business Services, Not Elsewhere Classified"
}
["employee_count"]=>
int(658)
["article_count"]=>
int(3439)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(150) "Advancing Healthcare Access: ScreenHer initiative in Pakistan close to reaching milestone of 20,000 diabetes screenings in 70 clinics | Macau Business"
["snippet_en"]=>
string(71) "Media OutReach | A collaboration between Roche Diabetes Care and social"
["url"]=>
string(162) "https://www.macaubusiness.com/advancing-healthcare-access-screenher-initiative-in-pakistan-close-to-reaching-milestone-of-20000-diabetes-screenings-in-70-clinics/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/36e93176-d574-477a-b8db-0ab7f3778d2b"
["source"]=>
string(17) "macaubusiness.com"
["publication_date"]=>
string(10) "2024-02-25"
["categories"]=>
array(3) {
[0]=>
string(13) "Collaboration"
[1]=>
string(24) "Access and affordability"
[2]=>
string(16) "Customer Welfare"
}
}
[1]=>
array(7) {
["title_en"]=>
string(87) "Roche and HM Hospitals join forces to research, train and advance in precision medicine"
["snippet_en"]=>
string(150) "The agreement, signed by the general director of the pharmacy and the president of HM, also seeks to “favor patients' access to innovation” and..."
["url"]=>
string(125) "https://www.plantadoce.com/empresa/roche-y-hm-hospitales-se-alian-para-investigar-formarse-y-avanzar-en-medicina-de-precision"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/83936ff3-f575-4495-aaf8-1d466244d10a"
["source"]=>
string(14) "plantadoce.com"
["publication_date"]=>
string(10) "2024-02-22"
["categories"]=>
array(3) {
[0]=>
string(13) "Collaboration"
[1]=>
string(24) "Access and affordability"
[2]=>
string(17) "Academic Research"
}
}
[2]=>
array(7) {
["title_en"]=>
string(83) "NEW REPORT SHOWS PATIENTS VALUE NHS DIAGNOSTIC SERVICES BUT FACE BARRIERS TO ACCESS"
["snippet_en"]=>
string(302) "London, 13th February 2024 – UK patients want better access to early and accurate diagnosis of health problems, according to new survey data from the Patients Association. Many patients would consider paying to get tests done privately if they faced a long wait for NHS tests. Nine in ten (90%) of..."
["url"]=>
string(127) "https://salford.media/news/local-news/new-report-shows-patients-value-nhs-diagnostic-services-but-face-barriers-to-access-r606/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/561b0d6a-bc92-4d2a-b5fb-545bf7a97a32"
["source"]=>
string(13) "salford.media"
["publication_date"]=>
string(10) "2024-02-13"
["categories"]=>
array(3) {
[0]=>
string(13) "Collaboration"
[1]=>
string(24) "Access and affordability"
[2]=>
string(16) "Customer Welfare"
}
}
[3]=>
array(7) {
["title_en"]=>
string(71) "How Black Clinical Trial Participation Can End Health Care Inequalities"
["snippet_en"]=>
string(165) "Black Americans can respond differently to medical treatments. Learn why genetics and environment cause racial drug discrepancies and how trials provide better care."
["url"]=>
string(96) "https://blackdoctor.org/how-black-clinical-trial-participation-can-end-health-care-inequalities/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b17265f8-204f-40fd-b9c5-d021e432aec0"
["source"]=>
string(15) "blackdoctor.org"
["publication_date"]=>
string(10) "2024-02-04"
["categories"]=>
array(1) {
[0]=>
string(24) "Access and affordability"
}
}
[4]=>
array(7) {
["title_en"]=>
string(40) "Roche Shares Fall on Modest 2024 Outlook"
["snippet_en"]=>
string(221) "US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education."
["url"]=>
string(136) "https://money.usnews.com/investing/news/articles/2024-02-01/roche-forecasts-return-to-growth-in-2024-as-it-overcomes-drop-in-covid-sales"
["image_url"]=>
NULL
["source"]=>
string(10) "usnews.com"
["publication_date"]=>
string(10) "2024-02-01"
["categories"]=>
array(9) {
[0]=>
string(24) "Access and affordability"
[1]=>
string(18) "General Investment"
[2]=>
string(16) "Share Repurchase"
[3]=>
string(31) "Financial Update/Profit Warning"
[4]=>
string(14) "Issuing Shares"
[5]=>
string(17) "Academic Research"
[6]=>
string(15) "Market Movement"
[7]=>
string(24) "Quarterly/Annual Figures"
[8]=>
string(12) "Stock Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(72) "Health finances a new therapy for agnostic tumors and a rare lung cancer"
["snippet_en"]=>
string(150) "This is entrectinib, a molecule developed by Roche that is now available for patients aged 12 and older with locally advanced solid tumors | SER Chain"
["url"]=>
string(139) "https://cadenaser.com/nacional/2024/01/24/sanidad-financia-una-nueva-terapia-para-tumores-agnosticos-y-un-cancer-de-pulmon-raro-cadena-ser/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fd5f2669-d9b3-41a4-a736-ef5ba81cdbe0"
["source"]=>
string(13) "cadenaser.com"
["publication_date"]=>
string(10) "2024-01-24"
["categories"]=>
array(3) {
[0]=>
string(16) "Customer Welfare"
[1]=>
string(24) "Access and affordability"
[2]=>
string(14) "Product Launch"
}
}
[6]=>
array(7) {
["title_en"]=>
string(109) "In the future, Roche will conduct research together with the University Hospital and the University of Zurich"
["snippet_en"]=>
string(157) "Roche enters into a research collaboration with the University Hospital and the University of Zurich. The aim is to improve patient care with real word data."
["url"]=>
string(108) "https://www.nau.ch/news/schweiz/roche-forscht-kunftig-zusammen-mit-unispital-und-universitat-zurich-66693290"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0cd2dc85-9d4e-434a-ad88-db5382fd00ab"
["source"]=>
string(6) "nau.ch"
["publication_date"]=>
string(10) "2024-01-23"
["categories"]=>
array(5) {
[0]=>
string(24) "Access and affordability"
[1]=>
string(16) "Customer Welfare"
[2]=>
string(5) "R & D"
[3]=>
string(17) "Academic Research"
[4]=>
string(13) "Collaboration"
}
}
[7]=>
array(7) {
["title_en"]=>
string(38) "GIANT Health London 9-10 December 2024"
["snippet_en"]=>
string(78) "GIANT Health is an international community of people whose business is health."
["url"]=>
string(84) "https://www.giant.health/blog/815/european-commission-approves-roches-tecentriq-sc_-"
["image_url"]=>
NULL
["source"]=>
string(12) "giant.health"
["publication_date"]=>
string(10) "2024-01-19"
["categories"]=>
array(5) {
[0]=>
string(16) "Customer Welfare"
[1]=>
string(24) "Access and affordability"
[2]=>
string(36) "Human Rights and Community Relations"
[3]=>
string(24) "Employee Health & Safety"
[4]=>
string(22) "EU Political Evolution"
}
}
[8]=>
array(7) {
["title_en"]=>
string(87) "Roche's Tecentriq, the super-fast intravenous cancer therapy waiting to arrive in Spain"
["snippet_en"]=>
string(91) "Roche's Tecentriq, the new super-fast intravenous cancer therapy waiting to arrive in Spain"
["url"]=>
string(57) "https://www.merca2.es/2024/01/18/roche-tecentriq-1545673/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3ee7ac60-bacc-46d6-b196-5daf1d9b96ce"
["source"]=>
string(9) "merca2.es"
["publication_date"]=>
string(10) "2024-01-18"
["categories"]=>
array(1) {
[0]=>
string(24) "Access and affordability"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(217)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(204)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(192)
}
[3]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(156)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(153)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(148)
}
[6]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(137)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(136)
}
[8]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(111)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(105)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(102)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(97)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(92)
}
[13]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(89)
}
[14]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(86)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(69)
}
[16]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(65)
}
[17]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(64)
}
[18]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(63)
}
[19]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(49)
}
[20]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(42)
}
[21]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(40)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(40)
}
[23]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(38)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(33)
}
[25]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(33)
}
[26]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(32)
}
[27]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(32)
}
[28]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(32)
}
[29]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(32)
}
}
}
ef866-gb-roche-diagnostics-limited
ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
https://diagnostics.roche.com
Articles
3439 Articles
Category
Business Services, Not Elsewhere Classified
Description
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
London, 13th February 2024 – UK patients want better access to early and accurate diagnosis of health problems, according to new survey data from the Patients Association. Many patients would consider paying to get tests done privately if they faced a long wait for NHS tests. Nine in ten (90%) of...
Black Americans can respond differently to medical treatments. Learn why genetics and environment cause racial drug discrepancies and how trials provide better care.
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Roche enters into a research collaboration with the University Hospital and the University of Zurich. The aim is to improve patient care with real word data.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
